Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 2
Quest Diagnostics completes acquisition of Haystack Oncology, adds MRD liquid biopsy to Dx portfolio
Quest expects next year to use the MRD technology in blood-based clinical lab testing services for solid tumor cancers.
June 21, 2023
Mars Petcare completes acquisition of Heska
Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling Mars to accelerate research and development and expand access to diagnostics and technology to more veterinary professionals and pets, Mars said.
June 13, 2023
Lighthouse Lab Services acquires Pathology Lab Solutions
Founded in 2008, Pathology Lab Solutions helps physician practices establish in-office pathology labs by advising on lab design, set-up, and ongoing compliance.
May 22, 2023
Labcorp acquires Providence Oregon laboratory assets
Under an agreement, providers and patients will have access to Providence Oregon facilities and services as well as Labcorp testing capabilities and expertise.
May 16, 2023
Bruker acquires digital platform provider Zontal
By integrating Zontal products, the Bruker IDS division plans to expand its vendor-agnostic software solutions portfolio for research, product development, and process optimization in life science, biopharma, and specialty chemicals.
May 8, 2023
As Q1 revenues slide, Quest inks deal to acquire liquid biopsy test developer Haystack Oncology
To acquire Haystack, the developer of a ctDNA-based test to detect MRD, Quest will pay $300 million in cash at closing and up to an additional $150 million on achieving future performance milestones.
April 27, 2023
Quest Diagnostics completes buy of some NewYork-Presbyterian lab assets
The goal of the deal is to enable providers and patients to access testing from a service menu that combines the complementary strengths of both organizations.
April 17, 2023
Mars to acquire veterinary diagnostics firm Heska for $120 per share
The transaction price represents a premium of approximately 23% over Heska's closing stock price on March 31, and the deal has been approved by the boards of directors of both companies.
April 3, 2023
Calibre Scientific acquires U.K. provider of scientific equipment, supplies, services
According to Calibre, SciQuip offers a broad and diversified portfolio whose product lines include centrifugation, incubation, ovens, freezers, freeze drying, liquid handling, and mission-critical laboratory equipment.
March 27, 2023
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Chembio “faces ongoing operational and financial challenges” if it remains an independent company, its CEO wrote in a letter to stockholders.
March 15, 2023
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Immucor's transfusion and transplant product lines complement Werfen's hemostasis, acute care, and autoimmunity business lines, and expand the parent firm's portfolio of specialized diagnostic products for hospitals and clinical laboratories.
March 15, 2023
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
The company said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs.
March 13, 2023
Previous Page
Page 2 of 9
Next Page
